APO Research

APO RESEARCH · REPORT

Monoclonal Mouse Antibody

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

Product & engineering

Understand the product.

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

Selected research

Market Structure

Global Monoclonal Mouse Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

The key players are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals and Seattle Genetics, etc, with about 57% market shares.

This report provides an overview of the global Monoclonal Mouse Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Monoclonal Mouse Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Monoclonal Mouse Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Monoclonal Mouse Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.

Monoclonal Mouse Antibody Segment by Company

Roche

Johnson & Johnson

Merck

Novartis

AbbVie

Amgen

Pfizer

Bayer

Lilly

Bristol-Myers Squibb

GlaxoSmithKline

Biogen

AstraZeneca

Sanofi

Alexion Pharmaceuticals

Seattle Genetics

Monoclonal Mouse Antibody Segment by Type

IgM

IgG

IgA

Others

Monoclonal Mouse Antibody Segment by Application

Therapeutic

Research

Diagnostic

ELISA kits

Monoclonal Mouse Antibody Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monoclonal Mouse Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Monoclonal Mouse Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monoclonal Mouse Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Monoclonal Mouse Antibody market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Monoclonal Mouse Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Monoclonal Mouse Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Monoclonal Mouse Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Monoclonal Mouse Antibody Industry Trends Table 2. Monoclonal Mouse Antibody Industry Drivers Table 3. Monoclonal Mouse Antibody Industry Opportunities and Challenges Table 4. Monoclonal Mouse Antibody Industry Restraints Table 5. Global Monoclonal Mouse Antibody Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Monoclonal Mouse Antibody Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Monoclonal Mouse Antibody Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Monoclonal Mouse Antibody Sales Market Share by Manufacturers Table 9. Global Monoclonal Mouse Antibody Average Sales Price (USD/g) of Manufacturers (2021-2026) Table 10. Global Monoclonal Mouse Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Monoclonal Mouse Antibody Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Monoclonal Mouse Antibody Manufacturers, Product Type & Application Table 13. Global Monoclonal Mouse Antibody Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Monoclonal Mouse Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of IgM Table 17. Major Manufacturers of IgG Table 18. Major Manufacturers of IgA Table 19. Major Manufacturers of Others Table 20. Global Monoclonal Mouse Antibody Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 21. Global Monoclonal Mouse Antibody Sales by Type (2021-2026) & (Kg) Table 22. Global Monoclonal Mouse Antibody Sales by Type (2027-2032) & (Kg) Table 23. Global Monoclonal Mouse Antibody Sales Market Share by Type (2021-2026) Table 24. Global Monoclonal Mouse Antibody Sales Market Share by Type (2027-2032) Table 25. Global Monoclonal Mouse Antibody Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 26. Global Monoclonal Mouse Antibody Revenue by Type (2021-2026) & (Kg) Table 27. Global Monoclonal Mouse Antibody Revenue by Type (2027-2032) & (Kg) Table 28. Global Monoclonal Mouse Antibody Revenue Market Share by Type (2021-2026) Table 29. Global Monoclonal Mouse Antibody Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Therapeutic Table 31. Major Manufacturers of Research Table 32. Major Manufacturers of Diagnostic Table 33. Major Manufacturers of ELISA kits Table 34. Global Monoclonal Mouse Antibody Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 35. Global Monoclonal Mouse Antibody Sales by Application (2021-2026) & (Kg) Table 36. Global Monoclonal Mouse Antibody Sales by Application (2027-2032) & (Kg) Table 37. Global Monoclonal Mouse Antibody Sales Market Share by Application (2021-2026) Table 38. Global Monoclonal Mouse Antibody Sales Market Share by Application (2027-2032) Table 39. Global Monoclonal Mouse Antibody Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 40. Global Monoclonal Mouse Antibody Revenue by Application (2021-2026) & (Kg) Table 41. Global Monoclonal Mouse Antibody Revenue by Application (2027-2032) & (Kg) Table 42. Global Monoclonal Mouse Antibody Revenue Market Share by Application (2021-2026) Table 43. Global Monoclonal Mouse Antibody Revenue Market Share by Application (2027-2032) Table 44. Global Monoclonal Mouse Antibody Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 45. Global Monoclonal Mouse Antibody Sales by Region (2021-2026) & (Kg) Table 46. Global Monoclonal Mouse Antibody Sales Market Share by Region (2021-2026) Table 47. Global Monoclonal Mouse Antibody Sales Forecasted by Region (2027-2032) & (Kg) Table 48. Global Monoclonal Mouse Antibody Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Monoclonal Mouse Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 50. North America Monoclonal Mouse Antibody Sales by Country (2021-2026) & (Kg) Table 51. North America Monoclonal Mouse Antibody Sales by Country (2027-2032) & (Kg) Table 52. Europe Monoclonal Mouse Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 53. Europe Monoclonal Mouse Antibody Sales by Country (2021-2026) & (Kg) Table 54. Europe Monoclonal Mouse Antibody Sales by Country (2027-2032) & (Kg) Table 55. Asia Pacific Monoclonal Mouse Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Asia Pacific Monoclonal Mouse Antibody Sales by Country (2021-2026) & (Kg) Table 57. Asia Pacific Monoclonal Mouse Antibody Sales by Country (2027-2032) & (Kg) Table 58. South America, Middle East and Africa Monoclonal Mouse Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 59. South America, Middle East and Africa Monoclonal Mouse Antibody Sales by Country (2021-2026) & (Kg) Table 60. South America, Middle East and Africa Monoclonal Mouse Antibody Sales by Country (2027-2032) & (Kg) Table 61. Global Monoclonal Mouse Antibody Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Monoclonal Mouse Antibody Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Monoclonal Mouse Antibody Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Monoclonal Mouse Antibody Revenue Market Share by Region (2021-2026) Table 65. Global Monoclonal Mouse Antibody Revenue Market Share by Region (2027-2032) Table 66. Roche Company Information Table 67. Roche Business Overview Table 68. Roche Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Roche Monoclonal Mouse Antibody Product Portfolio Table 70. Roche Recent Development Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Johnson & Johnson Monoclonal Mouse Antibody Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Merck Monoclonal Mouse Antibody Product Portfolio Table 80. Merck Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Novartis Monoclonal Mouse Antibody Product Portfolio Table 85. Novartis Recent Development Table 86. AbbVie Company Information Table 87. AbbVie Business Overview Table 88. AbbVie Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. AbbVie Monoclonal Mouse Antibody Product Portfolio Table 90. AbbVie Recent Development Table 91. Amgen Company Information Table 92. Amgen Business Overview Table 93. Amgen Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Amgen Monoclonal Mouse Antibody Product Portfolio Table 95. Amgen Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Pfizer Monoclonal Mouse Antibody Product Portfolio Table 100. Pfizer Recent Development Table 101. Bayer Company Information Table 102. Bayer Business Overview Table 103. Bayer Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Bayer Monoclonal Mouse Antibody Product Portfolio Table 105. Bayer Recent Development Table 106. Lilly Company Information Table 107. Lilly Business Overview Table 108. Lilly Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Lilly Monoclonal Mouse Antibody Product Portfolio Table 110. Lilly Recent Development Table 111. Bristol-Myers Squibb Company Information Table 112. Bristol-Myers Squibb Business Overview Table 113. Bristol-Myers Squibb Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Bristol-Myers Squibb Monoclonal Mouse Antibody Product Portfolio Table 115. Bristol-Myers Squibb Recent Development Table 116. GlaxoSmithKline Company Information Table 117. GlaxoSmithKline Business Overview Table 118. GlaxoSmithKline Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. GlaxoSmithKline Monoclonal Mouse Antibody Product Portfolio Table 120. GlaxoSmithKline Recent Development Table 121. Biogen Company Information Table 122. Biogen Business Overview Table 123. Biogen Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Biogen Monoclonal Mouse Antibody Product Portfolio Table 125. Biogen Recent Development Table 126. AstraZeneca Company Information Table 127. AstraZeneca Business Overview Table 128. AstraZeneca Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. AstraZeneca Monoclonal Mouse Antibody Product Portfolio Table 130. AstraZeneca Recent Development Table 131. Sanofi Company Information Table 132. Sanofi Business Overview Table 133. Sanofi Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Sanofi Monoclonal Mouse Antibody Product Portfolio Table 135. Sanofi Recent Development Table 136. Alexion Pharmaceuticals Company Information Table 137. Alexion Pharmaceuticals Business Overview Table 138. Alexion Pharmaceuticals Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Alexion Pharmaceuticals Monoclonal Mouse Antibody Product Portfolio Table 140. Alexion Pharmaceuticals Recent Development Table 141. Seattle Genetics Company Information Table 142. Seattle Genetics Business Overview Table 143. Seattle Genetics Monoclonal Mouse Antibody Sales (Kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Seattle Genetics Monoclonal Mouse Antibody Product Portfolio Table 145. Seattle Genetics Recent Development Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Monoclonal Mouse Antibody Distributors List Table 149. Monoclonal Mouse Antibody Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Monoclonal Mouse Antibody Product Image Figure 2. Global Monoclonal Mouse Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Monoclonal Mouse Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global Monoclonal Mouse Antibody Sales (2021-2032) & (Kg) Figure 5. Global Monoclonal Mouse Antibody Average Price (USD/g) & (2021-2032) Figure 6. Global Top 5 and 10 Monoclonal Mouse Antibody Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. IgM Image Figure 9. IgG Image Figure 10. IgA Image Figure 11. Others Image Figure 12. Global Monoclonal Mouse Antibody Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 13. Global Monoclonal Mouse Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Monoclonal Mouse Antibody Sales Market Share by Type (2021-2032) Figure 15. Global Monoclonal Mouse Antibody Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 16. Global Monoclonal Mouse Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Monoclonal Mouse Antibody Revenue Market Share by Type (2021-2032) Figure 18. Therapeutic Image Figure 19. Research Image Figure 20. Diagnostic Image Figure 21. ELISA kits Image Figure 22. Global Monoclonal Mouse Antibody Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 23. Global Monoclonal Mouse Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Monoclonal Mouse Antibody Sales Market Share by Application (2021-2032) Figure 25. Global Monoclonal Mouse Antibody Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 26. Global Monoclonal Mouse Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Monoclonal Mouse Antibody Revenue Market Share by Application (2021-2032) Figure 28. North America Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 29. North America Monoclonal Mouse Antibody Sales Market Share by Country (2021-2032) Figure 30. U.S. Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Canada Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Mexico Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 33. Europe Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 34. Europe Monoclonal Mouse Antibody Sales Market Share by Country (2021-2032) Figure 35. Germany Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 36. France Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 37. U.K. Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Italy Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Netherlands Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 40. Asia Pacific Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Asia Pacific Monoclonal Mouse Antibody Sales Market Share by Country (2021-2032) Figure 42. China Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Japan Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 44. South Korea Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 45. Southeast Asia Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 46. India Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 47. Australia Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 48. South America, Middle East and Africa Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South America, Middle East and Africa Monoclonal Mouse Antibody Sales Market Share by Country (2021-2032) Figure 50. Brazil Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 51. South Africa Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Saudi Arabia Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 53. Turkey Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Argentina Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 55. UAE Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 56. Egypt Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 57. Chile Monoclonal Mouse Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 58. Global Monoclonal Mouse Antibody Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Monoclonal Mouse Antibody Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Monoclonal Mouse Antibody Revenue (2021-2032) & (US$ Million) Figure 61. North America Monoclonal Mouse Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Monoclonal Mouse Antibody Revenue (2021-2032) & (US$ Million) Figure 63. Europe Monoclonal Mouse Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Monoclonal Mouse Antibody Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Monoclonal Mouse Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Monoclonal Mouse Antibody Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Monoclonal Mouse Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Monoclonal Mouse Antibody Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Monoclonal Mouse Antibody Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • IgM
  • IgG
  • IgA
  • Others
Applications
  • Therapeutic
  • Research
  • Diagnostic
  • ELISA kits
Companies covered
  • Roche
  • Johnson & Johnson
  • Merck
  • Novartis
  • AbbVie
  • Amgen
  • Pfizer
  • Bayer
  • Lilly
  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Biogen
  • AstraZeneca
  • Sanofi
  • Alexion Pharmaceuticals
  • Seattle Genetics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Monoclonal Mouse Antibody Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Monoclonal Mouse Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Monoclonal Mouse Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Monoclonal Mouse Antibody Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Monoclonal Mouse Antibody Market Dynamics
  1. 2.1 Monoclonal Mouse Antibody Industry Trends
  2. 2.2 Monoclonal Mouse Antibody Industry Drivers
  3. 2.3 Monoclonal Mouse Antibody Industry Opportunities and Challenges
  4. 2.4 Monoclonal Mouse Antibody Industry Restraints
3 Monoclonal Mouse Antibody Market by Manufacturers
  1. 3.1 Global Monoclonal Mouse Antibody Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Monoclonal Mouse Antibody Sales by Manufacturers (2021-2026)
  3. 3.3 Global Monoclonal Mouse Antibody Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Monoclonal Mouse Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Monoclonal Mouse Antibody Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Monoclonal Mouse Antibody Manufacturers, Product Type & Application
  7. 3.7 Global Monoclonal Mouse Antibody Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Monoclonal Mouse Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Monoclonal Mouse Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Monoclonal Mouse Antibody Tier 1, Tier 2, and Tier 3
4 Monoclonal Mouse Antibody Market by Type
  1. 4.1 Monoclonal Mouse Antibody Type Introduction
  2. 4.1.1 IgM
  3. 4.1.2 IgG
  4. 4.1.3 IgA
  5. 4.1.4 Others
  6. 4.2 Global Monoclonal Mouse Antibody Sales by Type
  7. 4.2.1 Global Monoclonal Mouse Antibody Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Monoclonal Mouse Antibody Sales by Type (2021-2032)
  9. 4.2.3 Global Monoclonal Mouse Antibody Sales Market Share by Type (2021-2032)
  10. 4.3 Global Monoclonal Mouse Antibody Revenue by Type
  11. 4.3.1 Global Monoclonal Mouse Antibody Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Monoclonal Mouse Antibody Revenue by Type (2021-2032)
  13. 4.3.3 Global Monoclonal Mouse Antibody Revenue Market Share by Type (2021-2032)
5 Monoclonal Mouse Antibody Market by Application
  1. 5.1 Monoclonal Mouse Antibody Application Introduction
  2. 5.1.1 Therapeutic
  3. 5.1.2 Research
  4. 5.1.3 Diagnostic
  5. 5.1.4 ELISA kits
  6. 5.2 Global Monoclonal Mouse Antibody Sales by Application
  7. 5.2.1 Global Monoclonal Mouse Antibody Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Monoclonal Mouse Antibody Sales by Application (2021-2032)
  9. 5.2.3 Global Monoclonal Mouse Antibody Sales Market Share by Application (2021-2032)
  10. 5.3 Global Monoclonal Mouse Antibody Revenue by Application
  11. 5.3.1 Global Monoclonal Mouse Antibody Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Monoclonal Mouse Antibody Revenue by Application (2021-2032)
  13. 5.3.3 Global Monoclonal Mouse Antibody Revenue Market Share by Application (2021-2032)
6 Global Monoclonal Mouse Antibody Sales by Region
  1. 6.1 Global Monoclonal Mouse Antibody Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Monoclonal Mouse Antibody Sales by Region (2021-2032)
  3. 6.2.1 Global Monoclonal Mouse Antibody Sales by Region (2021-2026)
  4. 6.2.2 Global Monoclonal Mouse Antibody Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Monoclonal Mouse Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Monoclonal Mouse Antibody Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Monoclonal Mouse Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Monoclonal Mouse Antibody Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Monoclonal Mouse Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Monoclonal Mouse Antibody Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Monoclonal Mouse Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Monoclonal Mouse Antibody Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Monoclonal Mouse Antibody Revenue by Region
  1. 7.1 Global Monoclonal Mouse Antibody Revenue by Region
  2. 7.1.1 Global Monoclonal Mouse Antibody Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Monoclonal Mouse Antibody Revenue by Region (2021-2026)
  4. 7.1.3 Global Monoclonal Mouse Antibody Revenue by Region (2027-2032)
  5. 7.1.4 Global Monoclonal Mouse Antibody Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Monoclonal Mouse Antibody Revenue (2021-2032)
  8. 7.2.2 North America Monoclonal Mouse Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Monoclonal Mouse Antibody Revenue (2021-2032)
  11. 7.3.2 Europe Monoclonal Mouse Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Monoclonal Mouse Antibody Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Monoclonal Mouse Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Monoclonal Mouse Antibody Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Monoclonal Mouse Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Monoclonal Mouse Antibody Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Monoclonal Mouse Antibody Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Monoclonal Mouse Antibody Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Monoclonal Mouse Antibody Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 AbbVie
  26. 8.5.1 AbbVie Company Information
  27. 8.5.2 AbbVie Business Overview
  28. 8.5.3 AbbVie Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AbbVie Monoclonal Mouse Antibody Product Portfolio
  30. 8.5.5 AbbVie Recent Developments
  31. 8.6 Amgen
  32. 8.6.1 Amgen Company Information
  33. 8.6.2 Amgen Business Overview
  34. 8.6.3 Amgen Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Amgen Monoclonal Mouse Antibody Product Portfolio
  36. 8.6.5 Amgen Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Monoclonal Mouse Antibody Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Monoclonal Mouse Antibody Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Lilly
  50. 8.9.1 Lilly Company Information
  51. 8.9.2 Lilly Business Overview
  52. 8.9.3 Lilly Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lilly Monoclonal Mouse Antibody Product Portfolio
  54. 8.9.5 Lilly Recent Developments
  55. 8.10 Bristol-Myers Squibb
  56. 8.10.1 Bristol-Myers Squibb Company Information
  57. 8.10.2 Bristol-Myers Squibb Business Overview
  58. 8.10.3 Bristol-Myers Squibb Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bristol-Myers Squibb Monoclonal Mouse Antibody Product Portfolio
  60. 8.10.5 Bristol-Myers Squibb Recent Developments
  61. 8.11 GlaxoSmithKline
  62. 8.11.1 GlaxoSmithKline Company Information
  63. 8.11.2 GlaxoSmithKline Business Overview
  64. 8.11.3 GlaxoSmithKline Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GlaxoSmithKline Monoclonal Mouse Antibody Product Portfolio
  66. 8.11.5 GlaxoSmithKline Recent Developments
  67. 8.12 Biogen
  68. 8.12.1 Biogen Company Information
  69. 8.12.2 Biogen Business Overview
  70. 8.12.3 Biogen Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biogen Monoclonal Mouse Antibody Product Portfolio
  72. 8.12.5 Biogen Recent Developments
  73. 8.13 AstraZeneca
  74. 8.13.1 AstraZeneca Company Information
  75. 8.13.2 AstraZeneca Business Overview
  76. 8.13.3 AstraZeneca Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AstraZeneca Monoclonal Mouse Antibody Product Portfolio
  78. 8.13.5 AstraZeneca Recent Developments
  79. 8.14 Sanofi
  80. 8.14.1 Sanofi Company Information
  81. 8.14.2 Sanofi Business Overview
  82. 8.14.3 Sanofi Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sanofi Monoclonal Mouse Antibody Product Portfolio
  84. 8.14.5 Sanofi Recent Developments
  85. 8.15 Alexion Pharmaceuticals
  86. 8.15.1 Alexion Pharmaceuticals Company Information
  87. 8.15.2 Alexion Pharmaceuticals Business Overview
  88. 8.15.3 Alexion Pharmaceuticals Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Alexion Pharmaceuticals Monoclonal Mouse Antibody Product Portfolio
  90. 8.15.5 Alexion Pharmaceuticals Recent Developments
  91. 8.16 Seattle Genetics
  92. 8.16.1 Seattle Genetics Company Information
  93. 8.16.2 Seattle Genetics Business Overview
  94. 8.16.3 Seattle Genetics Monoclonal Mouse Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Seattle Genetics Monoclonal Mouse Antibody Product Portfolio
  96. 8.16.5 Seattle Genetics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Monoclonal Mouse Antibody Value Chain Analysis
  2. 9.1.1 Monoclonal Mouse Antibody Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Monoclonal Mouse Antibody Production Mode & Process
  6. 9.2 Monoclonal Mouse Antibody Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Monoclonal Mouse Antibody Distributors
  9. 9.2.3 Monoclonal Mouse Antibody Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research